title: Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment.
abstract: The preferential metastasis of breast cancer cells to bone comprises a complex set of events including homing and preferential growth, which may require unique factors produced by bone or other cells in the immediate microenvironment. In this study, an in vitro co-culture system composed of bone mesenchymal stem cells and breast cancer cell lines is used to examine the role of Src kinase on breast cancer cell migration and invasion in the presence of bone-derived cells. This research shows that Src kinase activity in breast cancer cell lines with either high or low levels of endogenous Src activity is increased by bone-derived cell-conditioned medium but not HS68 fibroblast-conditioned medium. Breast cancer cells exhibit enhanced migration in co-culture with bone-derived cells but not HS68 fibroblasts or no co-cultured cells. Inhibition of Src kinase activity using the inhibitors PP2 or saracatinib or using siRNA abrogates the preferential migration of the breast cancer cell lines in response to bone-derived cells. Inhibition of Src activity with saracatinib does not have any significant effect on breast cancer cell invasion in the presence of bone-derived cells. Factors are identified that are produced preferentially by bone-derived cells over HS68 cells that may impact breast cancer cell behavior. This research implicates Src kinase as an important effector of bone-derived cell signals on breast cancer cell migration.
authors: Department of Oncology, Faculty of Medicine, University of Calgary, 1331 29 St, NW, Calgary, AB T2N 4N2, Canada.
authors: Brant
authors: B
authors: Pohorelic
authors: R
authors: R
authors: Singh
authors: S
authors: S
authors: Parkin
authors: K
authors: K
authors: Koro
authors: A-D
authors: AD
authors: Yang
authors: C
authors: C
authors: Egan
authors: A
authors: A
authors: Magliocco
mesh_terms: D052117:Benzodioxoles / Q000494:pharmacology; D001859:Bone Neoplasms / Q000201:enzymology / Q000556:secondary*; D001842:Bone and Bones / Q000473:pathology; D001943:Breast Neoplasms / Q000201:enzymology / Q000473:pathology*; D045744:Cell Line, Tumor; D002465:Cell Movement; D018920:Coculture Techniques; D017077:Culture Media, Conditioned; D004789:Enzyme Activation; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D008297:Male; D059630:Mesenchymal Stem Cells / Q000473:pathology; D009361:Neoplasm Invasiveness; D020411:Oligonucleotide Array Sequence Analysis; D010766:Phosphorylation; D011499:Protein Processing, Post-Translational; D011799:Quinazolines / Q000494:pharmacology; D059016:Tumor Microenvironment; D019061:src-Family Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*
chemical_list: D052117:Benzodioxoles; D017077:Culture Media, Conditioned; D011799:Quinazolines; C515233:saracatinib; D019061:src-Family Kinases